22 min listen
Management of MET-Altered Non-Small Cell Lung Cancer with Dr Rebecca Heist
Management of MET-Altered Non-Small Cell Lung Cancer with Dr Rebecca Heist
ratings:
Length:
39 minutes
Released:
Nov 7, 2022
Format:
Podcast episode
Description
Dr Rebecca Heist from Massachusetts General Hospital Cancer Center in Boston, Massachusetts discusses recent therapeutic advances in the management of MET-altered non-small cell lung cancer.
CME information and select publications here (http://www.researchtopractice.com/OncologyTodayMETAlteredNSCLC22).
CME information and select publications here (http://www.researchtopractice.com/OncologyTodayMETAlteredNSCLC22).
Released:
Nov 7, 2022
Format:
Podcast episode
Titles in the series (100)
Dr Tom Lynch on Adjuvant EGFR TKIs in Lung Cancer and COVID-19 in Seattle: Dr Tom Lynch comments on the current status of oncology research and data soon to be presented from a Phase III trial evaluating the EGFR TKI osimertinib as adjuvant therapy for patients with non-small cell lung cancer and EGFR tumor mutations. by Oncology Today with Dr Neil Love